The antiproliferative effect of suramin on the cancer cell line SW-13 is mediated by the inhibition of transforming growth factor beta 1 (TGF- beta 1). - Danesi,R.; Agen,C.; Bernardini,N.; Costa,M.; Del Tacca,M. (Pharmacol Res, 1992)